http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Xenetic Biosciences (XBIO) Appoints Jeffrey Eisenberg as CEO
-
Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer
-
Xenetic Biosciences Reports 2017 Second Quarter Financial Results and Provides Business Update
-
Xenetic Biosciences (XBIO) Says Partner Shire (SHPG) Reports Positive Phase 1/2 Study Evaluating SHP656 to Treat Hemophilia A
-
Xenetic Biosciences Reports 2017 First Quarter Financial Results and Provides Business Update
-
Xenetic Biosciences Presents Case Study of PolyXen™ Platform Technology at the 13th Annual Protein Engineering Summit (PEGS) Boston
-
PatientsLikeMe and Shire Pharmaceuticals Collaborate to Study Rare Genetic Diseases
-
Xenetic Biosciences Reports 2016 Year End Financial Results and Provides Business Update
-
Xenetic Biosciences to Present at the 29th Annual ROTH Conference
-
Shire Launches 'Rare Count' Campaign to Personalize the Global Impact of Rare Diseases
-
Xenetic Biosciences (XBIO) Receives $3 Million Milestone Payment from Shire (SHPG)
-
Xenetic Biosciences Receives $3 Million Milestone Payment from Shire plc for PSA-Recombinant SHP656 in Development for Long-Acting Treatment for Hemophilia
-
Exelixis Announces Leadership Hires in Public Affairs and Business Development to Support Growth of Company and Pipeline
-
Albany Molecular Research (AMRI) Enters Multi-Year Supply Agreement with Shire
-
Multimedia Assets Available: Modern Technology and a Multi-Screen Lifestyle Viewed as Important Factors in Rising Prevalence of Dry Eye Disease
-
Modern Technology and a Multi-Screen Lifestyle Viewed as Important Factors in Rising Prevalence of Dry Eye Disease
-
Pre-Open Stock Movers 10/11: (KMPH) (SUPN) (TWLO) Higher; (RCII) (ILMN) (LITE) Lower (more...)
-
Merrimack Pharma (MACK) Announces Final Phase 3 NAPOLI-1 Study Results; Previous OS Advantage Maintained
-
Final Results of NAPOLI-1 Study Confirm Overall Survival and Progression-Free Survival Benefit for the ONIVYDE® Regimen for Patients with Metastatic Pancreatic Cancer
-
Pharma companies gain competitive advantage from 1 day Masterclass on Artificial Intelligence in Pharma sales and marketing
-
Merrimack's (MACK) ONIVYDE Receives Positive CHMP Opinion
-
Merrimack Announces ONIVYDE® Regimen Receives Positive CHMP Opinion in European Union
-
Bioengineered Organ Implant Developer HART Names Accomplished Biotechnology Executive Dr. Blaine McKee to its Board
-
Epsilon Signs New Multi-Year Agreement To Provide Global Database Marketing Services For Worldwide Biotechnology Leader Shire
-
Pre-Open Stock Movers 02/11: (NTWK) (EXPE) (TRIP) (CSCO) Higher; (FLO) (LPSN) (INCY) Lower (more...)
-
Pre-Open Stock Movers 12/15: (KTOV) (LL) (VRX) Higher; (NEOT) (KMT) (ZOES) Lower (more...)
-
Market Wrap: Suprise Dip in Confidence for Oct.; Apple Gains on iPhone Sales; Walgreens Boots Moves to Acquire Peer
-
Adi Mohanty Joins Michael D. West, PhD, as Co-CEO of BioTime, Inc.
-
Biotechs Pressured Following Clinton Tweet (IBB)
-
Top 10 News for 8/3 - 8/7: July Payroll Gains Fall Short; Twitter Bloodshed Continues; Cable Cutting Concern Hits Media Names
-
HighPoint Solutions and Veeva Systems Team Up to Deliver Industry-specific Master Data Management to Life Sciences Companies
-
Medtech Jobs Jump Thanks To Mergers, Biotech Has Most Efficient Employees
-
GenomeDx Announces Exclusive Marketing and Distribution Agreement for the Decipher Prostate Cancer Classifier in Israel and the Palestinian Authority
-
Shire Appoints Olivier Bohuon to its Board of Directors
-
OvaScience Expands Senior Team with Two New Key Hires
-
Druva Announces Fifth Consecutive Year of Impressive 100+ Percent Growth
-
Routes Europe Opens Amidst Global Open Skies Debate
-
Shire and Cincinnati Children's Establish Rare Disease Research Collaboration
-
Jeremy Bloom and Rand Fishkin to Keynote iPharma 2015: CBI's 14th Annual Marketing Innovation Summit
-
UPDATE: NPS Pharmaceuticals (NPSP) Active; Co Seeks Buyer - WSJ
-
Notable Mergers and Acquisitions of the Day 07/18: (GTIV) (ABBV)/(SHPG) (TWTR) (RDNT)
-
Streetinsider.com's Hot Lunchtime Reads 06/04: (TWTR) (MSFT) (GOOG) (NQ)

